194 related articles for article (PubMed ID: 2968397)
1. Plasma beta-thromboglobulin to platelet factor 4 ratios as indices of vascular complications in essential hypertension.
Gomi T; Ikeda T; Yuhara M; Sakurai J; Nakayama D; Ikegami F
J Hypertens; 1988 May; 6(5):389-92. PubMed ID: 2968397
[TBL] [Abstract][Full Text] [Related]
2. Platelet activation indices and apolipoproteins in hypertensive patients.
Catalano M; Belletti S; Russo U; Aronica A; Carzaniga G; Seregni R; Libretti A
J Hum Hypertens; 1988 Oct; 2(3):195-7. PubMed ID: 2976836
[TBL] [Abstract][Full Text] [Related]
3. [Changes in platelet function in patients with arterial hypertension].
Malý J; Pecka M; Pintérová E; Pidrman V; Bláha M; Siroký O; Jebavý L
Vnitr Lek; 1995 Jul; 41(7):458-61. PubMed ID: 7571480
[TBL] [Abstract][Full Text] [Related]
4. Plasma concentrations of platelet-specific proteins in different stages of essential hypertension: interactions between platelet aggregation, blood lipids and age.
Yamanishi J; Sano H; Saito K; Furuta Y; Fukuzaki H
Thromb Haemost; 1985 Aug; 54(2):539-43. PubMed ID: 2417354
[TBL] [Abstract][Full Text] [Related]
5. [In vivo platelet activation in mild arterial hypertension].
Guicheney P; Baudouin-Legros M; Meyer P
Arch Mal Coeur Vaiss; 1987 Jun; 80(6):808-11. PubMed ID: 2959230
[TBL] [Abstract][Full Text] [Related]
6. Activation of platelets in patients with chronic proliferative glomerulonephritis and the nephrotic syndrome.
Tomura S; Ida T; Kuriyama R; Chida Y; Takeuchi J; Motomiya T; Yamazaki H
Clin Nephrol; 1982 Jan; 17(1):24-30. PubMed ID: 6459902
[TBL] [Abstract][Full Text] [Related]
7. Platelet indexes in relation to target organ damage in high-risk hypertensive patients: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Nadar SK; Blann AD; Kamath S; Beevers DG; Lip GY
J Am Coll Cardiol; 2004 Jul; 44(2):415-22. PubMed ID: 15261941
[TBL] [Abstract][Full Text] [Related]
8. Effect of allergen-specific immunotherapy on plasma level of platelet factor 4 (PF-4) and beta-thromboglobulin (beta-TG), platelet activation markers in patients with house dust mite allergy.
Kasperska-Zajac A; Brzoza Z; Rogala B
Vaccine; 2007 May; 25(18):3595-8. PubMed ID: 17291641
[TBL] [Abstract][Full Text] [Related]
9. Beta-thromboglobulin and platelet aggregation in essential hypertension and the influence of prazosin therapy.
Okrucká A; Pechán J; Mikulecký M
Cor Vasa; 1990; 32(5):363-73. PubMed ID: 2149548
[TBL] [Abstract][Full Text] [Related]
10. Platelet aggregation, beta-thromboglobulin and platelet factor 4 in diabetes mellitus and in patients with vasculopathy.
Fritschi J; Christe M; Lämmle B; Marbet GA; Berger W; Duckert F
Thromb Haemost; 1984 Dec; 52(3):236-9. PubMed ID: 6241750
[TBL] [Abstract][Full Text] [Related]
11. Beta-TG and plasma catecholamines levels after sympathetic stimuli in hypertensives and patients with peripheral vascular disease.
Catalano M; Russo U; Belletti S; Colombo F; Belloni A; del Rosso G; Lombardi F; Libretti A
Thromb Haemost; 1990 Jun; 63(3):383-5. PubMed ID: 2144920
[TBL] [Abstract][Full Text] [Related]
12. Platelet function and fibrinolytic activity in hypertension: differential effects of calcium antagonists and beta-adrenergic receptor blockers.
Winther K; Gleerup G; Hedner T
J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S41-4. PubMed ID: 1725542
[TBL] [Abstract][Full Text] [Related]
13. Effects of adrenaline infusion on serum thromboxane B2 and plasma beta-thromboglobulin levels in hypertensive and normotensive subjects.
Douma S; Zamboulis C; Karagiannis A; Sinakos Z
Nouv Rev Fr Hematol (1978); 1992; 34(1):73-8. PubMed ID: 1387933
[TBL] [Abstract][Full Text] [Related]
14. Correlation of specific platelet activation markers with carotid arterial wall thickness.
Ghaddar HB; Cortes J; Salomaa V; Kark JD; Davis CE; Folsom AR; Heiss G; Stinson V; Wu KK
Thromb Haemost; 1995 Sep; 74(3):943-8. PubMed ID: 8571326
[TBL] [Abstract][Full Text] [Related]
15. Effect of cold pressor test and awareness of hypertension on platelet function in normotensive and hypertensive women.
Mundal HH; Nordby G; Lande K; Gjesdal K; Kjeldsen SE; Os I
Scand J Clin Lab Invest; 1993 Oct; 53(6):585-91. PubMed ID: 8266004
[TBL] [Abstract][Full Text] [Related]
16. [Lack of effect of low dose acetylsalicylic acid (100 mg/die) on thrombocyte survival and beta-thromboglobulin (beta-TG) and platelet factor 4 (PF 4) in patients with peripheral arterial occlusive disease].
Minar E; Ehringer H; Jung M; Koppensteiner R; Stümpflen A; Ahmadi R
Vasa Suppl; 1989; 27():244-6. PubMed ID: 2533741
[No Abstract] [Full Text] [Related]
17. [Clinical significance of the radioimmunological determination of beta-thromboglobulin and platelet factor 4].
Schernthaner G; Silberbauer K; Mühlhauser I; Willvonseder R
Acta Med Austriaca Suppl; 1979; 6():375-9. PubMed ID: 95543
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of thrombotic risk in type 2 diabetes: determination of platelet factor 4 and beta thromboglobulin].
Diop S; Ka-Cisse M; Toure-Fall AO; Diagne Fall-Sarr F; Diop SN; Thiam D; Diakhate L
Dakar Med; 2002; 47(2):247-51. PubMed ID: 15776686
[TBL] [Abstract][Full Text] [Related]
19. Assessment of platelet activity as expressed by plasma levels of platelet factor 4 and beta-thromboglobulin in patients with chronic idiopathic urticaria.
Kasperska-Zajac A; Rogala B; Nowakowski M
Exp Dermatol; 2005 Jul; 14(7):515-8. PubMed ID: 15946239
[TBL] [Abstract][Full Text] [Related]
20. [Platelet aggregation in whole blood with the impedance method in subjects with non-complicated essential arterial hypertension].
Craveri A; Lanfredini M; Casati R; Citella C
Minerva Med; 1988 Jun; 79(6):441-6. PubMed ID: 2967926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
